Neurovascular unit uncoupling in diabetic retinopathy: molecular mechanisms and stage-adapted therapeutic strategies
By
Jing Chen
Ling Zhang
July 1, 2026
Clinical Scorecard: Disruption of the Neurovascular Unit in Diabetic Retinopathy: Molecular Pathways and Tailored Therapeutic Approaches for Different Stages
At a Glance
Category Detail
Condition Diabetic Retinopathy Key Mechanisms Chronic hyperglycemia, oxidative stress, inflammation, impaired VEGF/Ang signaling, neurovascular uncoupling. Target Population Individuals with diabetes, particularly those at risk for vision loss. Care Setting Clinical settings focusing on diabetic complications and retinal health.
Key Highlights
Diabetic retinopathy is a major neurovascular complication of diabetes. Neurovascular uncoupling occurs before visible vascular lesions. Early functional abnormalities can be detected in patients with diabetes. Current therapies include anti-VEGF agents and corticosteroids. Future treatments may focus on neuroprotection and metabolic reprogramming. Guideline-Based Recommendations
Diagnosis
Utilize electrophysiology, OCT, OCTA, and molecular biomarkers for early detection. Management
Implement mechanism-based treatment strategies tailored to individual patient profiles. Monitoring & Follow-up
Regular assessment of retinal function and structure to detect early changes. Risks
Chronic hyperglycemia and systemic metabolic dysregulation contribute to disease progression. Patient & Prescribing Data
Patients with diabetes at risk for diabetic retinopathy.
Established therapies focus on vascular stabilization and emerging strategies target neuroprotection and inflammation.
Clinical Best Practices
Reframe diabetic retinopathy as a neurovascular disorder rather than solely a vascular disease. Consider early intervention strategies to preserve neuronal function. Stratify patients based on dominant pathogenic features for tailored treatment. Related Resources & Content
